Similar articles

• Response to Mycobacterium tuberculosis antigens is enhanced by monoclonal antibodies.

  Damiani G, Soprani R, Rapallo A, Bisio S, Wang J. Damiani G, et al. Boll Soc Ital Biol Sper. 1991 May;67(5):517-9. Boll Soc Ital Biol Sper. 1991. PMID: 1805883
• Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.

  Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D; RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group. Hamdi H, et al. Arthritis Res Ther. 2006;8(4):R114. doi: 10.1186/ar1994. Arthritis Res Ther. 2006. PMID: 16859506 Free PMC article.
• Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis.

  Kadival GV, Chaparas SD, Hussong D. Kadival GV, et al. J Immunol. 1987 Oct 1;139(7):2447-51. J Immunol. 1987. PMID: 2443566
• Identification of a specific Mycobacterium tuberculosis protein able to activate T lymphocytes.

  Vismara D, Favaro M, Mariani F, Piccolella E, Colizzi V. Vismara D, et al. Ann Ist Super Sanita. 1991;27(1):21-6. Ann Ist Super Sanita. 1991. PMID: 1720294 Review.
• The 38-kDa protein of Mycobacterium tuberculosis: a review.

  Harboe M, Wiker HG. Harboe M, et al. J Infect Dis. 1992 Oct;166(4):874-84. doi: 10.1093/infdis/166.4.874. J Infect Dis. 1992. PMID: 1527425 Review.